HSA updates on products found overseas that contain potent ingredients (May 2025)
Paxlovid Available for High-Risk Covid-19 Patients in Singapore, but No Longer Free
New drug indication approval – April 2025
New drug approvals – April 2025
New drug indication approval – March 2025

The Health Sciences Authority (HSA) intends to inform the public about items discovered and reported by international authorities in May 2025. These items were found to contain powerful components that

|
June 8, 2025

Singapore's Ministry of Health (MOH) has confirmed that there is sufficient stockpile of Paxlovid, an oral antiviral drug used to treat Covid-19 in adults at risk of progressing to severe

|
May 23, 2025

Login to read more For the most updated information related to registered therapeutic products, please refer to the Register of Therapeutic Products. Product NameBOTOX® POWDER FOR SOLUTION FOR INJECTION 50

|
May 17, 2025

Login to read more For the most updated information related to registered therapeutic products, please refer to the Register of Therapeutic Products. Product NameABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN

|
May 17, 2025

Login to read more For the most updated information related to registered therapeutic products, please refer to the Register of Therapeutic Products. Product NameIMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50

|
May 17, 2025
Filter

Copyright © 2025 DocMed Technology Pte Ltd. All rights reserved.